Risk groups and stages
. | . | Stage, no. patients (%) . | . | . | . | . | . | . | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Risk group . | No. patients (%) . | I . | II . | III . | IV CNS- . | IV CNS+ . | B-AL CNS- . | B-AL CNS+ . | ||||||
| R1 | 48 (10) | 18 | 30 | 0 | 0 | 0 | 0 | 0 | ||||||
| R2 | 233 (46) | 35 | 89 | 109 | 0 | 0 | 0 | 0 | ||||||
| R3 | 82 (16) | 0 | 0 | 65 | 8 | 0 | 9 | 0 | ||||||
| R4 | 142 (28) | 0 | 0 | 47 | 8 | 17 | 47 | 23 | ||||||
| All | 505 (100) | 53 (10) | 119 (24) | 221 (44) | 16 (3) | 17 (3) | 56 (11) | 23 (5) | ||||||
. | . | Stage, no. patients (%) . | . | . | . | . | . | . | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Risk group . | No. patients (%) . | I . | II . | III . | IV CNS- . | IV CNS+ . | B-AL CNS- . | B-AL CNS+ . | ||||||
| R1 | 48 (10) | 18 | 30 | 0 | 0 | 0 | 0 | 0 | ||||||
| R2 | 233 (46) | 35 | 89 | 109 | 0 | 0 | 0 | 0 | ||||||
| R3 | 82 (16) | 0 | 0 | 65 | 8 | 0 | 9 | 0 | ||||||
| R4 | 142 (28) | 0 | 0 | 47 | 8 | 17 | 47 | 23 | ||||||
| All | 505 (100) | 53 (10) | 119 (24) | 221 (44) | 16 (3) | 17 (3) | 56 (11) | 23 (5) | ||||||